1. Home
  2. OLMA vs NETD Comparison

OLMA vs NETD Comparison

Compare OLMA & NETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • NETD
  • Stock Information
  • Founded
  • OLMA 2006
  • NETD 2023
  • Country
  • OLMA United States
  • NETD United States
  • Employees
  • OLMA N/A
  • NETD N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • NETD
  • Sector
  • OLMA Health Care
  • NETD
  • Exchange
  • OLMA Nasdaq
  • NETD Nasdaq
  • Market Cap
  • OLMA 289.0M
  • NETD 417.9M
  • IPO Year
  • OLMA 2020
  • NETD 2023
  • Fundamental
  • Price
  • OLMA $4.67
  • NETD $11.02
  • Analyst Decision
  • OLMA Strong Buy
  • NETD
  • Analyst Count
  • OLMA 3
  • NETD 0
  • Target Price
  • OLMA $27.67
  • NETD N/A
  • AVG Volume (30 Days)
  • OLMA 902.4K
  • NETD 153.5K
  • Earning Date
  • OLMA 05-16-2025
  • NETD 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • NETD N/A
  • EPS Growth
  • OLMA N/A
  • NETD N/A
  • EPS
  • OLMA N/A
  • NETD 0.45
  • Revenue
  • OLMA N/A
  • NETD N/A
  • Revenue This Year
  • OLMA N/A
  • NETD N/A
  • Revenue Next Year
  • OLMA N/A
  • NETD N/A
  • P/E Ratio
  • OLMA N/A
  • NETD $24.43
  • Revenue Growth
  • OLMA N/A
  • NETD N/A
  • 52 Week Low
  • OLMA $2.86
  • NETD $10.50
  • 52 Week High
  • OLMA $16.62
  • NETD $11.10
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 50.50
  • NETD 60.54
  • Support Level
  • OLMA $4.35
  • NETD $11.00
  • Resistance Level
  • OLMA $5.74
  • NETD $11.03
  • Average True Range (ATR)
  • OLMA 0.40
  • NETD 0.04
  • MACD
  • OLMA -0.02
  • NETD 0.00
  • Stochastic Oscillator
  • OLMA 25.26
  • NETD 38.46

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About NETD Nabors Energy Transition Corp. II

Nabors Energy Transition Corp II is a blank check company.

Share on Social Networks: